Delivery Order SPE2DB20D1100-SPE2DB22FA1J5
Award Date
2/16/22
Potential Completion Date
3/10/22
Potential Value
$164K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 300 mg/10 ml vials of the pharmaceutical OCREVUS. The $69,354.24 award is for delivery by February 1, 2024. Amerisourcebergen Drug Corp, which operates out of its corporate office in Conshohocken, Pennsylvania, has an extensive history of supplying pharmaceuticals and medical supplies to DLA, including under an indefinite...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 300 mg/10 mL vials of the pharmaceutical drug Ocrevus. The order, valued at $225,307.20, is scheduled for completion by June 21, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor for DLA Troop Support Medical, supplying a range of pharmaceutical products and medical supplies to...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide OCREVUS 300 MG/10 ML VIAL 10ML pharmaceutical products. The $124,402.96 contract is for supplies to be delivered by March 14, 2023. AmerisourceBergen Drug Corp, as the prime contractor, will fulfill this order from its corporate office located in Conshohocken, Pennsylvania. No set-aside designation was used...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 mg/10 ml vials. The total potential value of the award is $128,918.52, with a completion date of October 15, 2021. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 300 mg/10 ml vials of the pharmaceutical product OCREVUS. The $107,432.10 contract has a completion date of December 8, 2021 and was awarded on November 16, 2021. Amerisourcebergen Drug Corp has provided a range of pharmaceutical products and medical supplies to support Defense Logistics Agency programs. This...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of OCREVUS 300 mg/10 ml vial 10 ml. The contract has a potential value of $67,856.16 and a completion date of January 12, 2024. The award was made on December 20, 2023, and no set-aside designation was used. AmerisourceBergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical products...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of OCREVUS 300 MG/10 ML VIAL 10ML, a pharmaceutical product, with a potential value of $109,309.50 and a completion date of March 3, 2022. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract awards from DLA to supply pharmaceuticals,...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $196,757.10 firm fixed price delivery order is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a completion date of June 7, 2022 and was awarded on May 16, 2022. Amerisourcebergen Drug Corp, through its...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 300 mg/10 ml vials of the pharmaceutical product OCREVUS. The $112,653.60 delivery order has a completion date of May 25, 2023 and was awarded on May 4, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceuticals, medical supplies, and...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 MG/10 ML VIAL 10ML. The delivery order has a potential value of $109,309.50 and a completion date of March 3, 2022. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA Troop Support Medical to provide pharmaceutical products...